NO20005954D0 - Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse - Google Patents

Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse

Info

Publication number
NO20005954D0
NO20005954D0 NO20005954A NO20005954A NO20005954D0 NO 20005954 D0 NO20005954 D0 NO 20005954D0 NO 20005954 A NO20005954 A NO 20005954A NO 20005954 A NO20005954 A NO 20005954A NO 20005954 D0 NO20005954 D0 NO 20005954D0
Authority
NO
Norway
Prior art keywords
meiosis
infertility
stimulant
camp
treatment
Prior art date
Application number
NO20005954A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005954L (no
Inventor
Christa Hegele-Hartung
Quoc-Lam Cam
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20005954D0 publication Critical patent/NO20005954D0/no
Publication of NO20005954L publication Critical patent/NO20005954L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005954A 1998-05-26 2000-11-24 Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse NO20005954L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98250177 1998-05-26
PCT/EP1999/003138 WO1999061010A2 (fr) 1998-05-26 1999-05-07 TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE

Publications (2)

Publication Number Publication Date
NO20005954D0 true NO20005954D0 (no) 2000-11-24
NO20005954L NO20005954L (no) 2000-11-24

Family

ID=8234594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005954A NO20005954L (no) 1998-05-26 2000-11-24 Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse

Country Status (7)

Country Link
EP (1) EP1098652A2 (fr)
JP (1) JP2002516272A (fr)
KR (1) KR20010043828A (fr)
AU (1) AU5408999A (fr)
CA (1) CA2333320A1 (fr)
NO (1) NO20005954L (fr)
WO (1) WO1999061010A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148234A0 (en) 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
WO2001038493A1 (fr) * 1999-11-25 2001-05-31 Novo Nordisk A/S Traitement de l'infertilite humaine
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001248282A1 (en) 2000-04-06 2001-10-23 Novo-Nordisk A/S Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
EP1147774A1 (fr) * 2000-04-20 2001-10-24 Stichting Dienst Landbouwkundig Onderzoek Méthode d'amélioration de la qualité du sperme pour l'insémination artificielle des animaux
WO2001088098A2 (fr) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilisation d'oocytes ages
EP1245572A1 (fr) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation
EP1908463B1 (fr) * 2001-12-14 2011-09-28 Merck Serono SA Procédés d'induction d'ovulation utilisant un modulateur de niveau CAMP sans polypeptide
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
US9624278B2 (en) 2011-08-30 2017-04-18 Centre National De La Recherche Scientifique Protein complex comprising MCM8 and MCM9 proteins and their use
GB201117453D0 (en) * 2011-10-10 2011-11-23 Univ Dundee Improved sperm function/activity
CN108531447B (zh) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 调节精子运动能力及辅助生殖的化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196530A3 (fr) * 1985-03-26 1989-03-22 CTA Finanz AG Agent et procédé pour augmenter la croissance, optimiser la fécondité et stimuler le système immunitaire chez les humains et les animaux
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
US5800625A (en) * 1996-07-26 1998-09-01 Cauldron Limited Partnership Removal of material by radiation applied at an oblique angle
CA2199663C (fr) * 1997-03-11 2004-08-10 Ruth Miriam Moses Maturation et fecondation in vitro d'ovocytes mammaliens

Also Published As

Publication number Publication date
EP1098652A2 (fr) 2001-05-16
KR20010043828A (ko) 2001-05-25
AU5408999A (en) 1999-12-13
CA2333320A1 (fr) 1999-12-02
NO20005954L (no) 2000-11-24
JP2002516272A (ja) 2002-06-04
WO1999061010A3 (fr) 2000-04-27
WO1999061010A2 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
NO20005954D0 (no) Behandling av infertilitet med cAMP-ökende forbindelser alene eller i kombinasjon med minst én meiosestimulerende forbindelse
DK0927309T3 (da) Skrue med selvskærende gevind
TR199501053A2 (tr) Tedavide yararli spiro-azabisiklik bilesikler.
DK0792144T3 (da) Rengøringsvæv behandlet med vand-i-lipid emulsion
IS4785A (is) Tríazól afleiður, gagnlegar í meðhöndlun
ID26130A (id) Penyempurnaan-penyempurnaan dalam alat pengantar obat
BR9204375A (pt) Composicao e processo para o tratamento de agua de refrigeracao
ID28949A (id) Artikel-artikel penyerap yang menjaga atau memperbaiki kesehatan kulit
DE69700671D1 (de) Sicherungsmutter
DK0948719T3 (da) Fastgørelsesskrue med selvpløjende gevind
PT1015467E (pt) Derivados de eritromicina em ponte 6,9-
NO970631D0 (no) Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
DE69805242D1 (de) Titanaluminidlegierung
PT1211946E (pt) Processo de tratamento de carne fresca
ATA59298A (de) Fenster oder tür
ID28335A (id) Pengobatan serangan panik
KR960017879U (ko) 문짝 프레임의 결합 구조
DK0859899T3 (da) Dørlås som valgfrit kan anvendes højre- eller venstregående
PT1192156E (pt) Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
ES1041557Y (es) Disposicion de ajuste y proteccion aplicable en las embocaduras de prendas intimas y similares.
IT244770Y1 (it) Pannello per la costruzione di pareti di vasche , in particolare dipiscine
SE9301430D0 (sv) Foensterdekor med spenklackar
FI951185A0 (fi) Uppvaermnings- och ventilationssystem i samabnd med en ugn eller motsvarande
KR940020220U (ko) 온욕기

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application